Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aggeris™-C

K-Number: K220182 · 2022-03-30

ApplicantClariance
Decision Date2022-03-30
Product CodeKWQ
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Aggeris™-C is a medical device manufactured by Clariance. It received FDA 510(k) clearance on 2022-03-30 under approval number K220182. The device is classified under product code KWQ. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aggeris™-C?

Aggeris™-C is a medical device that received FDA 510(k) clearance on 2022-03-30. It is manufactured by Clariance. The 510(k) number is K220182.

When was Aggeris™-C approved by the FDA?

Aggeris™-C received FDA 510(k) clearance on 2022-03-30, under approval number K220182.

What company makes Aggeris™-C?

Aggeris™-C is manufactured by Clariance.

What is the FDA product code for Aggeris™-C?

The FDA product code for Aggeris™-C is KWQ.

Other Devices by Clariance

View all 7 devices →

Related Devices (Code: KWQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.